Community Pharmacy England (CPE) - News updates
Discontinuation of FreeStyle® Libre 3 Sensor
Pharmacy teams should be aware that FreeStyle® Libre 3 Sensor (Abbott Laboratories Ltd) has been discontinued and will be deleted from Part IX of the April 2026 Drug Tariff. Any NHS prescriptions for the FreeStyle® Libre 3 Sensor dispensed from 1 April 2026 will be disallowed by the NHS Business Services Authority (NHSBSA). Patients currently using the [...] The post Discontinuation of FreeStyle® Libre 3 Sensor appeared first on Community Pharmacy England.
Medicine Supply Notification: Sulfadiazine silver (Flamazine®) 1% cream
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfadiazine silver (Flamazine®) 1% cream. MSN/2026/007 Tier 2 – medium impact Date of issue: 10 February 2026 Sulfadiazine silver (Flamazine®) 1% cream (250g) was discontinued in late December 2025, stock has been exhausted. Sulfadiazine silver (Flamazine®) 1% cream (50g) was discontinued [...] The post Medicine Supply Notification: Sulfadiazine silver (Flamazine®) 1% cream appeared first on Community Pharmacy England.
Case study: Developing a community pharmacy-led LARC implant service in Liverpool
Background Liverpool has historically had a limited community pharmacy offer for sexual and reproductive health, with only six pharmacies commissioned to provide oral Emergency Contraception (EC). A new commissioner with a strong interest in community pharmacy led a programme of extensive stakeholder engagement as part of the city’s wider sexual health strategy. Liverpool LPC’s Chief [...] The post Case study: Developing a community pharmacy-led LARC implant service in Liverpool appeared first on Community Pharmacy England.
New CPPE Empowering pharmacy technicians to provide services workshop
The Centre for Pharmacy Postgraduate Education (CPPE) has launched a new workshop designed to equip pharmacy technicians with the competence and confidence to safely supply or administer medicines under Patient Group Directions (PGDs). The two-hour face-to-face workshop, which will be held at various locations throughout England, develops the practical skills needed to apply PGD frameworks, [...] The post New CPPE Empowering pharmacy technicians to provide services workshop appeared first on Community Pharmacy England.
C-19 vac: Setting up FDP access
Pharmacy owners taking part in the spring COVID-19 vaccination programme will require Federated Data Platform (FDP) access to order COVID-19 vaccines. Pharmacy owners can request FDP access here. A step-by-step guide is also available. If access issues occur, pharmacy owners should clear their browser cache, switch to Microsoft Edge or use an InPrivate/Incognito window and [...] The post C-19 vac: Setting up FDP access appeared first on Community Pharmacy England.
FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated
Update 06/02/2026: Updated to include additional products/batches: Product Batch code Expiry Aptamil First Infant Formula (800 g) All dates from 9 July 2026 to 4 December 2026 All dates from 9 July 2026 to 4 December 2026 Aptamil First Infant Formula (700 g) All dates from 22 August 2026 to 26 November 2026 All dates from 22 [...] The post FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated appeared first on Community Pharmacy England.
Improved prices for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the January 2026 concessionary price for Rosuvastatin 10mg tablets and Trimethoprim 100mg tablets: Drug Pack size Price concession Rosuvastatin 10mg tablets 28 £4.84 (previously £2.70) Trimethoprim 100mg tablets 28 £4.08 (previously £3.77) The [...] The post Improved prices for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026 appeared first on Community Pharmacy England.
MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management and cardiovascular risk reduction. Patients reporting a sudden loss of vision (including partial loss) while [...] The post MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) appeared first on Community Pharmacy England.
Rolled over price concessions for February 2026
The following price concessions granted in January 2026 have rolled over to February 2026: Drug Pack size January 2026 price concession Captopril 12.5mg tablets 56 £27.95 Captopril 25mg tablets 56 £25.95 Captopril 50mg tablets 56 £26.95 Codeine 15mg/5ml linctus sugar free 200 £17.34 Fusidic acid 1% modified-release eye drops 5 £35.00 Pyridoxine 10mg tablets 28 [...] The post Rolled over price concessions for February 2026 appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)
MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) Drug Alert Number: EL(26)A/07 Date issued: 04 February 2026 Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. DMRC reference [...] The post MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) appeared first on Community Pharmacy England.